Zusammenfassung
Patienten mit fortgeschrittener Herzinsuffizienz weisen oftmals auch eine begleitende Niereninsuffizienz auf. Diese enge pathophysiologische Interaktion wird als kardiorenales Syndrom (KRS) bezeichnet. Die hydropische Dekompensation ist bei diesen Patienten einer der häufigsten Hospitalisierungsgründe. Wenn trotz Optimierung der Therapie eine hydropische Dekompensation bzw. eine Diuretikaresistenz eintritt, kann eine Ultrafiltrationstherapie notwendig sein. In der akuten Dekompensation wird bei den oftmals intensivstationspflichtigen Patienten eine extrakorporale Nierenersatztherapie bevorzugt durchgeführt. Bei der chronischen Dekompensation, insbesondere wenn diese mit Aszitesbildung einhergeht, bietet eine peritoneale Ultrafiltration verfahrensspezifische Vorteile. Eine enge Kooperation zwischen Intensivmedizinern, Kardiologen und Nephrologen ist Voraussetzung für die optimale Behandlung des Patienten mit KRS.
Abstract
Renal failure is common in patients with severe heart failure and this complex pathophysiological interaction is classified as cardiorenal syndrome. In these patients hydropic decompensation is the main reason for hospitalization. In patients with refractory heart failure characterized by diuretic resistance and congestion due to volume overload, ultrafiltration has to be considered. In cases of acute decompensated heart failure with deterioration of renal function, extracorporeal ultrafiltration is the preferred treatment modality. On the other hand, patients suffering from chronic decompensated heart failure, particularly patients with ascites, will profit from the treatment-specific advantages of peritoneal ultrafiltration. A prerequisite for an optimized care of patients with cardiorenal syndrome is the close collaboration between intensive care physicians, cardiologists and nephrologists.
Literatur
McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart. Eur Heart J 33(14):1787–1847
Anavekar NS, McMurray JJV, Velazquez EJ et al (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351(13):1285–1295
Hillege HL, Girbes AR, Kam PJ de et al (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102(2):203–210
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348(20):2007–2018
Luthi J-C, Flanders WD, Burnier M et al (2006) Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients. BMC Nephrol 7:3
McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004–1009
Ronco C, McCullough P, Anker SD et al (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31(6):703–711
Ronco C, Cicoira M, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60(12):1031–1042
Shamseddin MK, Parfrey PS (2009) Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol 5(11):641–649
Sheppard R, Panyon J, Pohwani AL et al (2004) Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 10(5):380–383
Dini FL, Demmer RT, Simioniuc A et al (2012) Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. Eur J Heart Fail 14(3):287–294
Mullens W, Abrahams Z, Francis GS et al (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596
Testani JM, Khera AV, St John Sutton MG et al (2010) Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105(4):511–516
Dikow R, Kihm LP, Zeier M et al (2004) Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 15(6):1530–1536
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266
Swedberg K, Eneroth P, Kjekshus J, Snapinn S (1990) Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group. Am J Cardiol 66(11):40D–44D (discussion 44D–45D)
Mann JFE, Schmieder RE, McQueen M et al (2008) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638):547–553
Vardeny O, Wu DH, Desai A et al (2012) Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study). J Am Coll Cardiol 60(20):2082–2089
Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805
O’Connor CM, Abraham WT, Albert NM et al (2008) Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 156(4):662–673
Nationale Versorgungsleitlinie Herzinsuffizienz. http://www.herzinsuffizienz.versorgungsleitlinien.de/
Chertow GM, Normand S-LT, McNeil BJ (2004) „Renalism“: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 15(9):2462–2468
Feenstra J, Heerdink ER, Grobbee DE, Stricker BHC (2002) Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 162(3):265–270
Flather MD, Yusuf S, Køber L et al (2000) Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355(9215):1575–1581
Westenfeld R, Rump LC (2013) Contrast-induced nephropathy. Dtsch Med Wochenschr 138(14):715–718
Elahi M, Asopa S, Pflueger A et al (2009) Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality. Eur J Cardiothorac Surg 35(5):854–863
Payen D, Pont AC de, Sakr Y et al (2008) A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 12(3):R74
Udani SM, Murray PT (2009) The use of renal replacement therapy in acute decompensated heart failure. Semin Dial 22(2):173–179
Rubinger D, Backenroth R, Sapoznikov D (2012) Sympathetic activation and baroreflex function during intradialytic hypertensive episodes. PloS One 7(5):e36943
Marenzi G, Lauri G, Grazi M et al (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38(4):963–968
Bart BA, Boyle A, Bank AJ et al (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol 46(11):2043–2046
Jaski BE, Ha J, Denys BG et al (2003) Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 9(3):227–231
Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6):675–683
Bart BA, Goldsmith SR, Lee KL et al (2012) Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367(24):2296–2304
Testani JM, Brisco MA, Chen J et al (2013) Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62(6):516–524
Testani JM, Chen J, McCauley BD et al (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122(3):265–272
Jefferies HJ, Virk B, Schiller B et al (2011) Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 6(6):1326–1332
Selby NM, McIntyre CW (2011) Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int 31(1):27–33
Nakhoul F, Yigla M, Gilman R et al (2005) The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant 20(8):1686–1692
Ori Y, Korzets A, Katz M et al (1996) Haemodialysis arteriovenous access – a prospective haemodynamic evaluation. Nephrol Dial Transplant 11(1):94–97
Yigla M, Nakhoul F, Sabag A et al (2003) Pulmonary hypertension in patients with end-stage renal disease. Chest 123(5):1577–1582
Cnossen TT, Kooman JP, Krepel HP et al (2012) Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrol Dial Transplant 27(7):2794–2799
Moist LM, Port FK, Orzol SM et al (2000) Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11(3):556–564
Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16(11):2207–2213
Termorshuizen F, Korevaar JC, Dekker FW et al (2003) The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 41(6):1293–1302
Wang AY-M, Wang M, Woo J et al (2004) Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol 15(8):2186–2194
Cnossen TT, Kooman JP, Konings CJAM et al (2010) Peritoneal dialysis in patients with primary cardiac failure complicated by renal failure. Blood Purif 30(2):146–152
Nakayama M, Nakano H, Nakayama M (2010) Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis. J Cardiol 55(1):49–54
Ryckelynck JP, Lobbedez T, Valette B et al (1998) Peritoneal ultrafiltration and treatment-resistant heart failure. Nephrol Dial Transplant 13(Suppl 4):56–59
Sánchez JE, Ortega T, Rodríguez C et al (2010) Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrol Dial Transplant 25(2):605–610
Koch M, Haastert B, Kohnle M et al (2012) Peritoneal dialysis relieves clinical symptoms and is well tolerated in patients with refractory heart failure and chronic kidney disease. Eur J Heart Fail 14(5):530–539
Polkinghorne KR, Chin GK, Macginley RJ et al (2013) KHA-CARI guideline: vascular access – central venous catheters, arteriovenous fistulae and arteriovenous grafts. Nephrology (Carlton, Vic.) [Epub ahead of print]
Widmung
This paper is dedicated to our colleague and coauthor Prof. Dr. Bernd Krumme (04.09.1961–07.09.2013).
Einhaltung ethischer Richtlinien
Interessenkonflikt. V. Schwenger, B.A. Remppis, R. Westenfeld, T. Weinreich, R. Brunkhorst, R. Schmieder, G. Schlieper, B. Frye, U.C. Hoppe, J. Hoyer, T. Keller, M. Blumenstein, H. Schunkert, F. Mahfoud, L.C. Rump, G. Schieren, B. Krumme und H. Haller geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Additional information
___ ___
Dieser Artikel wurde in den Zeitschriften Der Kardiologe (DOI: 10.1007/s12181-013-0549-5) und Deutsche Medizinische Wochenschrift DMW (DOI: 10.1055/s-0033-1360037) zeitgleich publiziert.
Rights and permissions
About this article
Cite this article
Schwenger, V., Remppis, B., Westenfeld, R. et al. Dialyse- und Ultrafiltrationsverfahren bei kardiorenalem Syndrom. Kardiologe 8, 26–35 (2014). https://doi.org/10.1007/s12181-013-0549-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-013-0549-5